HEADER    BLOOD CLOTTING/HYDROLASE INHIBITOR      21-FEB-03   1O0D              
TITLE     HUMAN THROMBIN COMPLEXED WITH A D-PHE-PRO-ARG-TYPE INHIBITOR AND A C- 
TITLE    2 TERMINAL HIRUDIN DERIVED EXO-SITE INHIBITOR                          
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: THROMBIN LIGHT CHAIN;                                      
COMPND   3 CHAIN: L;                                                            
COMPND   4 FRAGMENT: LIGHT CHAIN;                                               
COMPND   5 SYNONYM: COAGULATION FACTOR II;                                      
COMPND   6 EC: 3.4.21.5;                                                        
COMPND   7 ENGINEERED: YES;                                                     
COMPND   8 MOL_ID: 2;                                                           
COMPND   9 MOLECULE: THROMBIN HEAVY CHAIN;                                      
COMPND  10 CHAIN: H;                                                            
COMPND  11 FRAGMENT: HEAVY CHAIN;                                               
COMPND  12 SYNONYM: COAGULATION FACTOR II;                                      
COMPND  13 EC: 3.4.21.5;                                                        
COMPND  14 ENGINEERED: YES;                                                     
COMPND  15 MOL_ID: 3;                                                           
COMPND  16 MOLECULE: DECAPEPTIDE HIRUDIN ANALOGUE;                              
COMPND  17 CHAIN: D;                                                            
COMPND  18 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 ORGAN: BLOOD;                                                        
SOURCE   6 GENE: F2;                                                            
SOURCE   7 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   8 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  10 MOL_ID: 2;                                                           
SOURCE  11 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE  12 ORGANISM_COMMON: HUMAN;                                              
SOURCE  13 ORGANISM_TAXID: 9606;                                                
SOURCE  14 ORGAN: BLOOD;                                                        
SOURCE  15 GENE: F2;                                                            
SOURCE  16 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE  17 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE  18 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  19 MOL_ID: 3;                                                           
SOURCE  20 SYNTHETIC: YES;                                                      
SOURCE  21 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS;                             
SOURCE  22 ORGANISM_COMMON: 6421                                                
KEYWDS    TERNARY COMPLEX; THROMBIN-ACTIVE-SITE INHIBITOR-EXO-SITE INHIBITOR,   
KEYWDS   2 BLOOD CLOTTING-HYDROLASE INHIBITOR COMPLEX                           
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    U.E.LANGE,D.BAUKE,W.HORNBERGER,H.MACK,W.SEITZ,H.W.HOEFFKEN            
REVDAT   6   04-APR-18 1O0D    1       REMARK                                   
REVDAT   5   11-OCT-17 1O0D    1       REMARK                                   
REVDAT   4   25-MAY-16 1O0D    1       SOURCE                                   
REVDAT   3   13-JUL-11 1O0D    1       VERSN                                    
REVDAT   2   24-FEB-09 1O0D    1       VERSN                                    
REVDAT   1   14-OCT-03 1O0D    0                                                
JRNL        AUTH   U.E.LANGE,D.BAUKE,W.HORNBERGER,H.MACK,W.SEITZ,H.W.HOEFFKEN   
JRNL        TITL   D-PHE-PRO-ARG TYPE THROMBIN INHIBITORS: UNEXPECTED           
JRNL        TITL 2 SELECTIVITY BY MODIFICATION OF THE P1 MOIETY                 
JRNL        REF    BIOORG.MED.CHEM.LETT.         V.  13  2029 2003              
JRNL        REFN                   ISSN 0960-894X                               
JRNL        PMID   12781189                                                     
JRNL        DOI    10.1016/S0960-894X(03)00236-1                                
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.44 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS                                                  
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-              
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,              
REMARK   3               : READ,RICE,SIMONSON,WARREN                            
REMARK   3                                                                      
REMARK   3  REFINEMENT TARGET : ENGH & HUBER                                    
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.44                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 50.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : NULL                           
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : NULL                           
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 6.5                            
REMARK   3   NUMBER OF REFLECTIONS             : 11792                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.199                           
REMARK   3   FREE R VALUE                     : 0.252                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : NULL                            
REMARK   3   FREE R VALUE TEST SET COUNT      : 889                             
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : NULL                            
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : NULL                         
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : NULL                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : NULL                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : NULL                         
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : NULL                         
REMARK   3   BIN R VALUE           (WORKING SET) : NULL                         
REMARK   3   BIN FREE R VALUE                    : NULL                         
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : NULL                         
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : NULL                         
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : NULL                         
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2400                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 33                                      
REMARK   3   SOLVENT ATOMS            : 174                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 35.07                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : NULL                           
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : NULL                                                 
REMARK   3    B22 (A**2) : NULL                                                 
REMARK   3    B33 (A**2) : NULL                                                 
REMARK   3    B12 (A**2) : NULL                                                 
REMARK   3    B13 (A**2) : NULL                                                 
REMARK   3    B23 (A**2) : NULL                                                 
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : NULL                            
REMARK   3   ESD FROM SIGMAA              (A) : NULL                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : NULL                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : NULL                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : NULL                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.007                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.407                           
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : NULL                            
REMARK   3   IMPROPER ANGLES        (DEGREES) : NULL                            
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : NULL                                      
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED : NULL                                                 
REMARK   3   KSOL        : NULL                                                 
REMARK   3   BSOL        : NULL                                                 
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1O0D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAR-03.                  
REMARK 100 THE DEPOSITION ID IS D_1000018416.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 01-FEB-98                          
REMARK 200  TEMPERATURE           (KELVIN) : 295.0                              
REMARK 200  PH                             : 8.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : N                                  
REMARK 200  RADIATION SOURCE               : ROTATING ANODE                     
REMARK 200  BEAMLINE                       : NULL                               
REMARK 200  X-RAY GENERATOR MODEL          : RIGAKU RU200                       
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.5418                             
REMARK 200  MONOCHROMATOR                  : GOEBEL MIRROR                      
REMARK 200  OPTICS                         : GOEBEL MIRROR                      
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : SIEMENS                            
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : X-GEN, SMART                       
REMARK 200  DATA SCALING SOFTWARE          : X-GEN                              
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 12245                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.440                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 50.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 1.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 90.0                               
REMARK 200  DATA REDUNDANCY                : 2.100                              
REMARK 200  R MERGE                    (I) : 0.07810                            
REMARK 200  R SYM                      (I) : 0.07810                            
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 16.0420                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.44                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.59                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 49.2                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 1.23                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.32550                            
REMARK 200  R SYM FOR SHELL            (I) : 0.32550                            
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 1.754                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: CNS                                                   
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 52.66                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 400, NA-ACETATE, TRIS, PH 8.5,       
REMARK 280  VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298.0K                   
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1                          
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y,-Z                                                 
REMARK 290       3555   X+1/2,Y+1/2,Z                                           
REMARK 290       4555   -X+1/2,Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   3  1.000000  0.000000  0.000000       35.44000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       35.98000            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000       35.44000            
REMARK 290   SMTRY2   4  0.000000  1.000000  0.000000       35.98000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1, 2                                                    
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC                          
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC                   
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 5030 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 12700 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, D                               
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 2                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC                  
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 11010 ANGSTROM**2                         
REMARK 350 SURFACE AREA OF THE COMPLEX: 24450 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, D                               
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   2  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400                                                                      
REMARK 400 THE HIRUDIN ANALOGUE IS OLIGOPEPTIDE, A MEMBER OF ANTICOAGULANT,     
REMARK 400 ANTITHROMBOTIC CLASS.                                                
REMARK 400                                                                      
REMARK 400  GROUP: 1                                                            
REMARK 400   NAME: HIRUDIN ANALOGUE                                             
REMARK 400   CHAIN: D                                                           
REMARK 400   COMPONENT_1: PEPTIDE LIKE POLYMER                                  
REMARK 400   DESCRIPTION: DECAPEPTIDE                                           
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     THR L     1H                                                     
REMARK 465     PHE L     1G                                                     
REMARK 465     TRP H   147A                                                     
REMARK 465     THR H   147B                                                     
REMARK 465     ALA H   147C                                                     
REMARK 465     ASN H   147D                                                     
REMARK 465     VAL H   147E                                                     
REMARK 465     GLY H   147F                                                     
REMARK 465     LYS H   147G                                                     
REMARK 465     GLY H   246                                                      
REMARK 465     GLU H   247                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    GLU L   1C     147.01    -33.39                                   
REMARK 500    PHE L   7      -86.90   -136.33                                   
REMARK 500    TYR L  14J      34.35    -83.52                                   
REMARK 500    ILE L  14K     -67.19   -161.10                                   
REMARK 500    SER H  48     -167.60   -169.94                                   
REMARK 500    TYR H  60A      75.06   -166.49                                   
REMARK 500    ASN H  60G      78.14   -165.71                                   
REMARK 500    HIS H  71      -53.11   -135.95                                   
REMARK 500    ASN H  78       -5.65     72.63                                   
REMARK 500    ASN H  98       21.31   -143.32                                   
REMARK 500    SER H 115     -168.19   -162.52                                   
REMARK 500    ASP H 170        8.20    -68.39                                   
REMARK 500    ARG H 175       99.12    -66.91                                   
REMARK 500    PRO H 186      -39.06    -38.50                                   
REMARK 500    SER H 214      -72.96   -117.33                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 615                                                                      
REMARK 615 ZERO OCCUPANCY ATOM                                                  
REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO                  
REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS                
REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;              
REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):         
REMARK 615   M RES C  SSEQI                                                     
REMARK 615     163 H   248                                                      
REMARK 630                                                                      
REMARK 630 MOLECULE TYPE: NULL                                                  
REMARK 630 MOLECULE NAME: (2-{2-[(5-CARBAMIMIDOYL-1-METHYL-1H-PYRROL-2-         
REMARK 630 YLMETHYL)-CARBAMOYL]-PYRROL-1-YL}- 1-CYCLOHEXYLMETHYL-2-OXO-         
REMARK 630 ETHYLAMINO)-ACETIC ACID                                              
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 630  SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                           
REMARK 630                                                                      
REMARK 630   M RES C SSSEQI                                                     
REMARK 630     163 H   248                                                      
REMARK 630 SOURCE: NULL                                                         
REMARK 630 TAXONOMY: NULL                                                       
REMARK 630 SUBCOMP:    01N PYC 01Q                                              
REMARK 630 DETAILS: NULL                                                        
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF DECAPEPTIDE HIRUDIN    
REMARK 800  ANALOGUE                                                            
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1PPB   RELATED DB: PDB                                   
REMARK 900 HUMAN THROMBIN WITH A DIFFERENT INHIBITOR                            
REMARK 900 RELATED ID: 1A5G   RELATED DB: PDB                                   
REMARK 900 SAME CRYSTAL FORM WITH A DIFFERENT C-TERMINAL HIRUDIN DERIVED        
REMARK 900 PEPTIDE                                                              
REMARK 900 RELATED ID: 1NZQ   RELATED DB: PDB                                   
DBREF  1O0D L    1H   15  UNP    P00734   THRB_HUMAN     328    363             
DBREF  1O0D H   16   247  UNP    P00734   THRB_HUMAN     364    622             
DBREF  1O0D D   55    65  PDB    1O0D     1O0D            55     65             
SEQRES   1 L   36  THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO          
SEQRES   2 L   36  LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG          
SEQRES   3 L   36  GLU LEU LEU GLU SER TYR ILE ASP GLY ARG                      
SEQRES   1 H  259  ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO          
SEQRES   2 H  259  TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU          
SEQRES   3 H  259  LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU          
SEQRES   4 H  259  THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS          
SEQRES   5 H  259  ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS          
SEQRES   6 H  259  HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE          
SEQRES   7 H  259  SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN          
SEQRES   8 H  259  TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS          
SEQRES   9 H  259  LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO          
SEQRES  10 H  259  VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU          
SEQRES  11 H  259  GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN          
SEQRES  12 H  259  LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN          
SEQRES  13 H  259  PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU          
SEQRES  14 H  259  ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR          
SEQRES  15 H  259  ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY          
SEQRES  16 H  259  LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO          
SEQRES  17 H  259  PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN          
SEQRES  18 H  259  MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP          
SEQRES  19 H  259  GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS          
SEQRES  20 H  259  LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU              
SEQRES   1 D   11  SIN TYR GLU PRO ILE HYP GLU GLU SMF ALC GLN                  
MODRES 1O0D HYP D   60  PRO  4-HYDROXYPROLINE                                   
MODRES 1O0D SMF D   63  PHE  4-SULFOMETHYL-L-PHENYLALANINE                      
MODRES 1O0D ALC D   64  ALA  2-AMINO-3-CYCLOHEXYL-PROPIONIC ACID                
HET    SIN  D  55       7                                                       
HET    HYP  D  60       8                                                       
HET    SMF  D  63      16                                                       
HET    ALC  D  64      11                                                       
HET    163  H 248      33                                                       
HETNAM     SIN SUCCINIC ACID                                                    
HETNAM     HYP 4-HYDROXYPROLINE                                                 
HETNAM     SMF 4-SULFOMETHYL-L-PHENYLALANINE                                    
HETNAM     ALC 2-AMINO-3-CYCLOHEXYL-PROPIONIC ACID                              
HETNAM     163 (2-{2-[(5-CARBAMIMIDOYL-1-METHYL-1H-PYRROL-2-YLMETHYL)-          
HETNAM   2 163  CARBAMOYL]-PYRROL-1-YL}- 1-CYCLOHEXYLMETHYL-2-OXO-              
HETNAM   3 163  ETHYLAMINO)-ACETIC ACID                                         
HETSYN     HYP HYDROXYPROLINE                                                   
FORMUL   3  SIN    C4 H6 O4                                                     
FORMUL   3  HYP    C5 H9 N O3                                                   
FORMUL   3  SMF    C10 H13 N O5 S                                               
FORMUL   3  ALC    C9 H17 N O2                                                  
FORMUL   4  163    C23 H32 N6 O4                                                
FORMUL   5  HOH   *174(H2 O)                                                    
HELIX    1   1 PHE L    7  SER L   11  5                                   5    
HELIX    2   2 THR L   14B SER L   14I 1                                   8    
HELIX    3   3 ALA H   55  CYS H   58  5                                   4    
HELIX    4   4 PRO H   60B ASP H   60E 5                                   4    
HELIX    5   5 THR H   60I ASN H   62  5                                   3    
HELIX    6   6 ASP H  125  LEU H  130  1                                   9    
HELIX    7   7 GLU H  164  ASP H  170  1                                   7    
HELIX    8   8 LEU H  234  PHE H  245  1                                  12    
HELIX    9   9 HYP D   60  ALC D   64  5                                   5    
SHEET    1   A 7 SER H  20  ASP H  21  0                                        
SHEET    2   A 7 GLN H 156  PRO H 161 -1  O  VAL H 157   N  SER H  20           
SHEET    3   A 7 LYS H 135  GLY H 140 -1  N  GLY H 136   O  LEU H 160           
SHEET    4   A 7 PRO H 198  LYS H 202 -1  O  VAL H 200   N  ARG H 137           
SHEET    5   A 7 TRP H 207  TRP H 215 -1  O  TYR H 208   N  MET H 201           
SHEET    6   A 7 GLY H 226  HIS H 230 -1  O  PHE H 227   N  TRP H 215           
SHEET    7   A 7 MET H 180  ALA H 183 -1  N  PHE H 181   O  TYR H 228           
SHEET    1   B 7 GLN H  30  ARG H  35  0                                        
SHEET    2   B 7 GLU H  39  LEU H  46 -1  O  CYS H  42   N  LEU H  33           
SHEET    3   B 7 TRP H  51  THR H  54 -1  O  LEU H  53   N  SER H  45           
SHEET    4   B 7 ALA H 104  LEU H 108 -1  O  ALA H 104   N  THR H  54           
SHEET    5   B 7 LYS H  81  ILE H  90 -1  N  TYR H  89   O  LEU H 105           
SHEET    6   B 7 LEU H  64  ILE H  68 -1  N  VAL H  66   O  SER H  83           
SHEET    7   B 7 GLN H  30  ARG H  35 -1  N  PHE H  34   O  LEU H  65           
SSBOND   1 CYS L    1    CYS H  122                          1555   1555  2.03  
SSBOND   2 CYS H   42    CYS H   58                          1555   1555  2.03  
SSBOND   3 CYS H  168    CYS H  182                          1555   1555  2.02  
SSBOND   4 CYS H  191    CYS H  220                          1555   1555  2.03  
LINK         C4  SIN D  55                 N   TYR D  56     1555   1555  1.33  
LINK         C   ILE D  59                 N   HYP D  60     1555   1555  1.33  
LINK         C   HYP D  60                 N   GLU D  61     1555   1555  1.33  
LINK         C   GLU D  62                 N   SMF D  63     1555   1555  1.35  
LINK         C   SMF D  63                 N   ALC D  64     1555   1555  1.34  
LINK         C   ALC D  64                 N   GLN D  65     1555   1555  1.33  
CISPEP   1 SER H   36A   PRO H   37          0        -0.10                     
SITE     1 AC1 17 HOH D  66  HOH D  67  LYS H  36  GLN H  38                    
SITE     2 AC1 17 LEU H  40  ASN H  62  LEU H  65  ARG H  73                    
SITE     3 AC1 17 THR H  74  ARG H  75  TYR H  76  LYS H  81                    
SITE     4 AC1 17 ILE H  82  MET H  84  HOH H 391  HOH H 392                    
SITE     5 AC1 17 HOH H 393                                                     
CRYST1   70.880   71.960   73.520  90.00 101.06  90.00 C 1 2 1       4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.014108  0.000000  0.002758        0.00000                         
SCALE2      0.000000  0.013897  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.013859        0.00000